The use of proton pump inhibitors (PPIs) has been associated with an increased risk of vitamin B12 deficiency, particular in older adults and those on long-term PPI therapy. Nutrition Reviews Duration-Dependent Risk Assessment The risk of B12 deficiency from PPIs grows with time
Standard Dosage Recommendations: Typical concentration: Available as a 10 mg/mL solution in 5 mL vials Daily dosage: 1-2 mg (0.03-0.06ml or 3-6 units) subcutaneously Alternative recommendation: 0.2 mL delivered subcutaneously once daily Injection concentration range: 0.1% to 1.0% Administration Schedule: Frequency: Daily injections, preferably at the same time each day Recommended schedule: Monday through Friday (with weekends off) Important note: Injectable GHK-Cu should be administered under professional supervision due to risks associated with self-injection Oral/Ingestible Options Oral administration of GHK-Cu requires special formulation to prevent breakdown in the digestive system
The key difference is in the specific formulations and their stability profiles, which vary by manufacturer and preparation method
Other parameters like growth velocity (in children), body composition, bone density, or general well-being can help assess effectiveness
FITC and PI fluorescence signals were measured, with unstained cells used as negative controls for gating
